in

A Groundbreaking New Shot That Can Block Severe Allergic Responses To Small Amounts Of Common Food Allergens Has Been Approved By The FDA And May Help Save Children From Life-Threatening Reactions

JenkoAtaman - stock.adobe.com - illustrative purposes only, not the actual people

According to the CDC, approximately 8% of children in the United States have food allergies. This translates to every one in 13 children or about two students per average school classroom.

But, an exciting breakthrough in treating food allergies might be on the horizon, offering hope for protecting children from severe allergic reactions.

Scientists at the Stanford School of Medicine have found that the medication omalizumab, known commercially as Xolair, can block the severe allergic responses triggered by small quantities of foods like peanuts, eggs, or milk.

This discovery has the potential to change the game for those living with food allergies, who face the daily danger of life-threatening incidents from unintentional encounters with these common allergens.

“Patients impacted by food allergies face a daily threat of life-threatening reactions due to accidental exposures. The study showed that omalizumab could be a layer of protection against small, accidental exposures,” said Dr. Robert Wood, the study’s lead author.

Xolair, which the FDA has previously approved for managing allergic asthma and chronic idiopathic urticaria– or chronic hives– operates by neutralizing IgE antibodies that trigger allergic reactions.

This pioneering research resulted in the FDA endorsing Xolair on February 16 as a treatment to lessen the danger of food-related allergic reactions, shining a ray of hope for individuals grappling with allergies to multiple foods.

In this study, 177 children with severe allergies to peanuts and at least two other foods participated. For four months, these children were given Xolair injections either monthly or every other month.

The outcomes were impressive: 66% of the 118 children who were treated with the drug could safely eat small quantities of foods that had once caused them allergic reactions.

JenkoAtaman – stock.adobe.com – illustrative purposes only, not the actual people

Sign up for Chip Chick’s newsletter and get stories like this delivered to your inbox.

1 of 3